Overnight in 2016, the treatment of hepatitis C virus (HCV) in Australia changed forever through the introduction of Direct-acting antivirals (DAAs) to the Australian Pharmaceutical Benefits Scheme (PBS). This month marks ten years since this vital turning point. Prior to this, treatment for HCV typically took place in a hospital setting and scripts had to be written by a […]
Exploring the clinical spectrum and health system impact of injection-related infections among incarcerated Australians who inject drugs. Dr Andrew Joseph Palmer will present on his research paper: Injection-related infections among incarcerated Australians who inject drugs: clinical spectrum, microbiology, and healthcare costs in a real-world hospital cohort. Date, Time, Platform: Presenters: Additional speakers TBC Learning Outcomes: On […]
People living with a blood-borne virus (BBV) in Australia experience legal issues at significantly higher rates than those without and commonly face multiple and overlapping legal problems at once. These findings come from Health+Law’s Legal Needs Study, which also found the majority of participants report their most serious legal issues are linked to, or worsened by, living with a BBV. As […]
This one-day face-to-face course provides nurses and midwives with practical knowledge and skills to support the screening, assessment, management and follow-up of hepatitis B and hepatitis C. The program covers epidemiology, testing and serology interpretation, vaccination and prevention, chronic disease monitoring, treatment pathways, and models of care. Emphasis is placed on culturally responsive, stigma-free practice […]
For the first time, ASHM has published an annual Global Impact Report to highlight achievements from the previous year and to serve as an update on how key projects across Asia and the Pacific are making positive change. The report can be viewed in its entirety here, but below are some of the notable highlights […]
This interactive face-to-face program equips primary care practitioners with the knowledge, skills, and confidence to test, diagnose, assess, manage, and treat hepatitis B and hepatitis C. Participants will explore evidence-based approaches to clinical management, treatment pathways, and ongoing support for individuals and families, with the goal of improving health outcomes and reducing the burden of […]
Increasing HCV treatment in primary care is crucial to achieving HCV elimination in Australia by 2030. This course aims to empower general practitioners, nurse practitioners and other prescribing practitioners with the skills and confidence to diagnose, assess, manage, and treat HCV in primary care. Training delivery utilises a blended learning approach with expert-led presentations and facilitated […]
This is an Expression of Interest page. By clicking “Register Now” your name will be added to a wait list. You will be notified to register via email when a session becomes available in your state of residence or practice.
This is an Expression of Interest page. By clicking “Register Now” your name will be added to a wait list. You will be notified to register via email when a session becomes available in your state of residence or practice.
What if the key to better hepatitis C care is rethinking what we mean by “culturally safe”? ASHM’s interactive Forum returns for its fourth year with a dynamic three-part design to challenge assumptions, centre lived experience and turn person-centred care into practical system change. Expect bold conversations, hands-on sessions and real-world strategies you can take straight […]
ASHM Head Office - Sydney
Level 3, 160 Clarence Street Sydney, NSW 2000
Tel: (+61) 02 8204 0700
ASHM acknowledges the Traditional Owners of Country across the various lands on which we live and work. We recognise Aboriginal and Torres Strait Islander peoples’ continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.
The information provided on this website and its related websites and guidelines, and the resources made available by ASHM in any format or medium, are for general information purposes only and are not intended as medical advice or as a substitute for consultation with a qualified healthcare professional. While ASHM Health strives to provide accurate and current resources and information, the resources, information and guidelines made available by ASHM Health do not provide personalised medical advice, diagnosis, or treatment. Healthcare professionals should apply their clinical judgment and consider individual circumstances when using this information. To the extent permitted by law, ASHM Health disclaims all liability for any outcomes resulting from reliance on the information provided. For specific medical concerns, please consult a licensed healthcare provider.
ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2024 ASHM